ValuePickr2 days ago
NEUTRAL(80%)
hold
Dishman Carbogen Amcis Ltd
Read original source+15.2
Market Impact Score
-100 Bearish+100 Bullish
AI Analysis
The CRAMS and API sectors are dynamic, with companies constantly adapting to market demands and regulatory changes. Small and mid-cap pharma stocks are often sensitive to broader market corrections.
Trading Insight
For Dishman, a long-term accumulation strategy might be considered if the generic API strategy proves successful and market sentiment improves.
Quick check: DISHMAN neutral, SUNPHARMA neutral (-1.4% 1d).
Key Evidence
- •Dishman Carbogen Amcis operates in CRAMS and generic API space.
- •Current market cap is 522 crores, CMP 65.
- •The company is shifting focus from QUATS to CRAMS and generic API to insulate revenues.
- •Stock experienced a sharp correction in line with other small and midcaps.
- •Risk flag: High competition in CRAMS and generic API.
Affected Stocks
DISHMANDishman Carbogen Amcis Ltd
Mixed
The article discusses the company's fundamentals and past stock performance, providing an overview rather than new impactful news.
Sectors:pharma
AI-powered analysis by
Anadi Algo News